Kesimpta الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

kesimpta

novartis ireland ltd - ofatumumab - multipel sklerose, recidiverende-remitterende - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Firazyr الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

firazyr

takeda pharmaceuticals international ag - icatibant - angioødemer, arvelige - hjertetapi - firazyr er indiceret til symptomatisk behandling af akutte angreb af arvelig angioødem (hae) hos voksne (med c1-esterase-hæmmere mangel).